rhodamine 123 has been researched along with loperamide in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertolini, A; Costantino, L; Forni, F; Leo, E; Rivasi, F; Ruozi, B; Tacchi, R; Tosi, G; Vandelli, MA; Vergoni, AV | 1 |
| Bertolini, A; Costantino, L; Tacchi, R; Tosi, G; Vandelli, MA; Vergoni, AV | 1 |
| Badiali, L; Benassi, R; Bondioli, L; Fano, RA; Forni, F; Rivasi, F; Ruozi, B; Tosi, G; Vandelli, MA | 1 |
| Gu, X; Sha, W; Shan, L; Sridhar, R; Sukumar, S; Zhou, Y | 1 |
| Li, H; Shen, GL; Sun, HX; Yuan, M; Zhuang, XM | 1 |
| Al-Jayyoussi, G; Eddershaw, P; Edwards, CD; Francombe, D; Gumbleton, M; Morris, C; Price, DF; Smith, MW; Taylor, G | 1 |
6 other study(ies) available for rhodamine 123 and loperamide
| Article | Year |
|---|---|
Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123.
Topics: Animals; Antidiarrheals; Blood-Brain Barrier; Brain; Drug Delivery Systems; Lactic Acid; Loperamide; Male; Nanoparticles; Oligopeptides; Pain Measurement; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Wistar; Rhodamine 123 | 2007 |
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution.
Topics: Animals; Biological Assay; Brain; Drug Delivery Systems; Injections, Intraventricular; Loperamide; Male; Nanoparticles; Nociceptors; Particle Size; Rats; Rats, Wistar; Rhodamine 123; Tissue Distribution | 2009 |
Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier.
Topics: Animals; Blood-Brain Barrier; Drug Delivery Systems; Glycopeptides; Lactic Acid; Loperamide; Male; Nanoparticles; Neurodegenerative Diseases; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Rhodamine 123; Tissue Distribution | 2011 |
Loperamide, an FDA-approved antidiarrhea drug, effectively reverses the resistance of multidrug resistant MCF-7/MDR1 human breast cancer cells to doxorubicin-induced cytotoxicity.
Topics: Antibiotics, Antineoplastic; Antidiarrheals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Loperamide; Rhodamine 123; RNA, Messenger | 2012 |
[Evaluation of P-glycoprotein mediated in vitro loperamide biliary excretion with sandwich-cultured rat hepatocytes model].
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biliary Tract; Cells, Cultured; Chromatography, High Pressure Liquid; Cyclosporine; Hepatocytes; Loperamide; Male; Quinidine; Quinolines; Rats; Rats, Sprague-Dawley; Rhodamine 123; Tandem Mass Spectrometry | 2012 |
Selectivity in the impact of P-glycoprotein upon pulmonary absorption of airway-dosed substrates: a study in ex vivo lung models using chemical inhibition and genetic knockout.
Topics: Animals; Anti-Arrhythmia Agents; Antidiarrheals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; Biological Transport; Digoxin; Dogs; Gene Knockout Techniques; HIV Protease Inhibitors; Humans; Loperamide; Lung; Madin Darby Canine Kidney Cells; Male; Mice; Mice, Knockout; Permeability; Rats; Rats, Sprague-Dawley; Rhodamine 123; Saquinavir | 2013 |